Baxter’s Board of Directors Declares Quarterly Dividend

DEERFIELD, Ill., May 5, 2009 – The Board of Directors of Baxter International Inc. (NYSE:BAX) today announced a quarterly dividend and the results of votes taken at the company’s Annual Meeting of Shareholders held earlier today.

Baxter’s Board of Directors declared a quarterly dividend of $0.26 per share of Baxter common stock. This payment represents a continuation of the current rate. The quarterly dividend is payable on July 1, 2009 to shareholders of record as of
June 10, 2009.

At its Annual Meeting of Shareholders held today in Chicago, Baxter shareholders re-elected four members of the company’s Board of Directors – Walter E. Boomer,
James R. Gavin III, M.D., Ph.D., Peter S. Hellman and K. J. Storm -- for a term of three years. Shareholders also ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Baxter, and voted against a shareholder proposal regarding animal testing.

A webcast replay of Baxter's Annual Meeting of Shareholders can be accessed from a link on the company's website at www.baxter.com. Please visit Baxter's website for more information regarding this and future investor events and webcasts.

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.